Botrocetin/VWF-induced signaling through GPIb-IX-V produces TxA2 in an αIIbβ3- and aggregation-independent manner

Por Liu, Junling, Pestina, Tamara I., Berndt, Michael C., Jackson, Carl W., Gartner, T. Kent
Publicado em 2005

Amelioration of murine β-thalassemia through drug selection of hematopoietic stem cells transduced with a lentiviral vector encoding both γ-globin and the MGMT drug-resistance gene...

Por Zhao, Huifen, Pestina, Tamara I., Nasimuzzaman, Md, Mehta, Perdeep, Hargrove, Phillip W., Persons, Derek A.
Publicado em 2009

Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model

Por Lebensburger, Jeffrey D., Pestina, Tamara I., Ware, Russell E., Boyd, Kelli L., Persons, Derek A.
Publicado em 2010

Correction of Murine Sickle Cell Disease Using γ-Globin Lentiviral Vectors to Mediate High-level Expression of Fetal Hemoglobin

Por Pestina, Tamara I, Hargrove, Phillip W, Jay, Dennis, Gray, John T, Boyd, Kelli M, Persons, Derek A
Publicado em 2008

Role of the Distal Half of the c-Mpl Intracellular Domain in Control of Platelet Production by Thrombopoietin In Vivo

Por Luoh, Shiuh-Ming, Stefanich, Eric, Solar, Gregg, Steinmetz, Hope, Lipari, Terry, Pestina, Tamara I., Jackson, Carl W., de Sauvage, Frederic J.
Publicado em 2000

Amelioration of murine sickle cell disease by nonablative conditioning and γ-globin gene-corrected bone marrow cells

Por Pestina, Tamara I, Hargrove, Phillip W, Zhao, Huifen, Mead, Paul E, Smeltzer, Matthew P, Weiss, Mitchell J, Wilber, Andrew, Persons, Derek A
Publicado no Mol Ther Methods Clin Dev (2015)

Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectin

Por Lebensburger, Jeffrey D., Howard, Thad, Hu, Yunming, Pestina, Tamara I., Gao, Geli, Johnson, Melissa, Zakharenko, Stanislav S., Ware, Russell E., Tuomanen, Elaine I., Persons, Derek A., Rosch, Jason W.
Publicado em 2012